| 臺大學術典藏 |
2021-10-04T07:15:45Z |
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities
|
Lee M.-R.; Tsai C.-J.; Hu J.-Y.; Lee S.-W.; JEN-CHANG KO; Wang H.-C.; Yu C.-J.; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-10-04T07:15:43Z |
Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan
|
Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-10-04T07:15:43Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
Lee M.-R.; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; JEN-CHANG KO; Yu C.-J.; Lin H.-H. |
| 臺大學術典藏 |
2021-10-04T07:15:42Z |
Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study
|
Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Yu C.-J. |
| 臺大學術典藏 |
2021-10-04T07:15:37Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-10-04T07:15:37Z |
Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs
|
Chang C.-H.; Lee C.-H.; JEN-CHANG KO; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:11Z |
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
|
Lee M.-R.; Yang C.-Y.; Chang K.-P.; LI-TA KENG; Yen D.H.-T.; Wang J.-Y.; Wu H.-D.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:11Z |
Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration
|
Lee M.-R.; LI-TA KENG; Shu C.-C.; Lee S.-W.; Lee C.-H.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-17T05:56:10Z |
Diagnostic role of inflammatory and anti-inflammatory cytokines and effector molecules of cytotoxic T lymphocytes in tuberculous pleural effusion
|
Shu C.-C.; Wang J.-Y.; Hsu C.-L.; LI-TA KENG; Tsui K.; Lin J.-F.; Lai H.-C.; Yu C.-J.; Lee L.-N.; Luh K.-T. |
| 臺大學術典藏 |
2021-09-17T05:56:10Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
LI-TA KENG; Shu C.-C.; Chen J.Y.P.; Liang S.-K.; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-09-17T05:56:09Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
Lin C.-H.; Hsieh S.-C.; LI-TA KENG; Lee H.-S.; Chang H.-T.; Liao W.-Y.; Ho C.-C.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:06Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
LI-TA KENG; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:03Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; LI-TA KENG; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:56:02Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
Lee M.-R.; Huang H.-L.; LI-TA KENG; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T05:41:27Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; KAI-LUN YU; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-17T03:21:21Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
Lee M.-R.; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; SHENG-KAI LIANG; Liao C.-H.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T03:21:20Z |
Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy
|
Keng L.-T.; Shu C.-C.; Chen J.Y.P.; SHENG-KAI LIANG; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N. |
| 臺大學術典藏 |
2021-09-17T03:21:18Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Keng L.-T.; Chung K.-P.; Lin S.-Y.; SHENG-KAI LIANG; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T03:21:16Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
SHENG-KAI LIANG; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:51:10Z |
CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates
|
MENG-RUI LEE; Cheng A.; Lee Y.-C.; Yang C.-Y.; Lai C.-C.; Huang Y.-T.; Ho C.-C.; Wang H.-C.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:10Z |
Bacteremia caused by Brevundimonas species at a tertiary care hospital in Taiwan, 2000-2010
|
MENG-RUI LEE; Huang Y.T.; Liao C.H.; Chuang T.Y.; Lin C.K.; Lee S.W.; Lai C.C.; Yu C.J.; Hsueh P.R. |
| 臺大學術典藏 |
2021-09-17T02:51:09Z |
Risk factors for Mycobacterium chelonae-abscessus pulmonary disease persistence and deterioration
|
MENG-RUI LEE; Keng L.-T.; Shu C.-C.; Lee S.-W.; Lee C.-H.; Wang J.-Y.; Lee L.-N.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-17T02:51:08Z |
Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria
|
MENG-RUI LEE; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; Liang S.-K.; Liao C.-H.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:08Z |
Epidemiologic surveillance to detect false-positive Mycobacterium tuberculosis cultures
|
MENG-RUI LEE; Chung K.-P.; Chen W.-T.; Huang Y.-T.; Lee L.-N.; Yu C.-J.; Teng L.-J.; Hsueh P.-R.; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2021-09-17T02:51:07Z |
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
|
MENG-RUI LEE; Yang C.-Y.; Chang K.-P.; Keng L.-T.; Yen D.H.-T.; Wang J.-Y.; Wu H.-D.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:51:06Z |
Evaluation of the Cobas TaqMan MTB real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory specimens
|
MENG-RUI LEE; Chung K.-P.; Wang H.-C.; Lin C.-B.; Yu C.-J.; Lee J.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:05Z |
Clinical characteristics and outcomes of patients with pleural infections due to Stenotrophomonas maltophilia at a medical center in Taiwan, 2004-2012
|
MENG-RUI LEE; Wang H.-C.; Yang C.-Y.; Lin C.-K.; Kuo H.-Y.; Ko J.-C.; Sheng W.-H.; Lee L.-N.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:04Z |
Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination
|
MENG-RUI LEE; Yang C.-Y.; Shu C.-C.; Lin C.-K.; Wen Y.-F.; Lee S.-W.; Ko J.-C.; Wang J.-Y.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:51:04Z |
High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis
|
Chuang T.-Y.; Chang H.-T.; Chung K.-P.; Cheng H.-S.; Liu C.-Y.; Liu Y.-C.; Huang H.-H.; Chou T.-C.; Chang B.-L.; MENG-RUI LEE; Lin C.-J.; Lee S.-W.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:03Z |
Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis
|
Chung K.-P.; Chang H.-T.; Lo S.-C.; Chang L.-Y.; Lin S.-Y.; Cheng A.; Huang Y.-T.; Chen C.-C.; MENG-RUI LEE; Chen Y.-J.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; Ho C.-C.; Huang M.-T.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-17T02:51:03Z |
Plasma biomarkers can predict treatment response in tuberculosis patients: A prospective observational study
|
MENG-RUI LEE; Tsai C.-J.; Wang W.-J.; Chuang T.-Y.; Yang C.-M.; Chang L.-Y.; Lin C.-K.; Wang J.-Y.; Shu C.-C.; Lee L.-N.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:51:01Z |
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities
|
MENG-RUI LEE; Tsai C.-J.; Hu J.-Y.; Lee S.-W.; Ko J.-C.; Wang H.-C.; Yu C.-J.; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:01Z |
Mycobacterium abscessus complex infections in humans
|
MENG-RUI LEE; Sheng W.-H.; Hung C.-C.; Yu C.-J.; Lee L.-N.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:00Z |
Clinical features of patients with bacteraemia caused by Mycobacterium avium complex species and antimicrobial susceptibility of the isolates at a medical centre in Taiwan, 2008–2014
|
MENG-RUI LEE; Chien J.-Y.; Huang Y.-T.; Liao C.-H.; Shu C.-C.; Yu C.-J.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-17T02:51:00Z |
Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis
|
MENG-RUI LEE; Huang Y.-P.; Kuo Y.-T.; Luo C.-H.; Shih Y.-J.; Shu C.-C.; Wang J.-Y.; Ko J.-C.; Yu C.-J.; Lin H.-H. |
| 臺大學術典藏 |
2021-09-17T02:50:55Z |
Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis
|
Huang C.-T.; MENG-RUI LEE; Ruan S.-Y.; Tsai Y.-J.; Wang J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:50:52Z |
Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort
|
Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; MENG-RUI LEE; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-17T02:50:51Z |
Establishing aspergillus-specific igg cut-off level for chronic pulmonary aspergillosis diagnosis: Multicenter prospective cohort study
|
MENG-RUI LEE; Huang H.-L.; Keng L.-T.; Chang H.-L.; Sheu C.-C.; Fu P.-K.; Wang J.-Y.; Chong I.-W.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-15T01:20:52Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU; Chang Y.-L.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-15T01:20:50Z |
Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis
|
Chung K.-P.; CHIA-LANG HSU; Fan L.-C.; Huang Z.; Bhatia D.; Chen Y.-J.; Hisata S.; Cho S.J.; Nakahira K.; Imamura M.; Choi M.E.; Yu C.-J.; Cloonan S.M.; Choi A.M.K. |
| 臺大學術典藏 |
2021-09-15T01:20:46Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; CHIA-LANG HSU; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-14T02:45:49Z |
Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003
|
Tseng W.-P.; JHONG-LIN WU; Wu C.-C.; Kuo K.-T.; Lin C.-H.; Chung M.-Y.; Lee Y.-F.; Yang B.-J.; Huang C.-H.; Chen S.-Y.; Yu C.-J.; Chen S.-C.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-09-09T05:25:29Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-09T05:25:27Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non�Vsmall-cell lung cancer patients
|
ZONG-HAN YAO; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-09-04T06:12:08Z |
Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load
|
Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; Lee L.-N.; JIA-HORNG KAO; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:34Z |
High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma
|
Yang C.-H.; ANN-LII CHENG; Yeh K.-H.; Yu C.-J.; Lin J.-F.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:18Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; ANN-LII CHENG; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:06Z |
A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma
|
Chen Y.-M.; Yu C.-J.; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; ANN-LII CHENG; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C. |
| 臺大學術典藏 |
2021-09-01T01:54:29Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; ANN-LII CHENG; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:28Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; ANN-LII CHENG; Pao W.; Yang P.-C. |
